ReviewCancers2020

Transmembrane Activator and CAML Interactor (TACI): Another Potential Target for Immunotherapy of Multiple Myeloma?

Shengli Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.